
Dr. Khushboo Rastogi is an experienced Radiation Oncologist serving as a Consultant in Radiation Oncology at BLK-Max Super Speciality Hospital, New Delhi. Her clinical practice focuses on radiation-based cancer treatment and the management of patients requiring specialised radiotherapy.
She completed her MBBS and MD in Radiation Oncology. She also holds a Certification Course in Essentials of Palliative Care (CCEPC) through the Indian Association of Palliative Care, adding further training in supportive care for patients with serious illnesses.
Her clinical interests include 3D Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Stereotactic Body Radiation Therapy (SBRT) and stereotactic radiosurgery. She also has experience in the radiation management of cancers involving the lungs, breast, thyroid, head and neck and gastrointestinal tract.
Through her association with BLK-Max, Dr. Rastogi contributes to specialist cancer care and radiation oncology services. Her training in radiotherapy and palliative care supports her clinical work in cancer treatment and the management of treatment-related healthcare needs.
Decades of expertise, proven results, and compassionate care — here is why patients from 50+ countries trust Dr. Khushboo Rastogi for Radiation Oncology treatment in India.
Over 20 years of dedicated clinical experience with 5,000+ procedures. One of the most trusted names in Radiation Oncology in India.
Dr. Khushboo Rastogi regularly treats patients from Africa, the Middle East, Central Asia, and Europe. Dedicated international patient support team available 24/7.
Practices at an internationally accredited hospital, ensuring patient safety standards that match the best hospitals in the USA and Europe.
World-class treatment at a fraction of USA, UK, or Australian prices. Transparent cost estimates provided before you travel.
Dr. Khushboo Rastogi holds postgraduate qualifications from premier Indian institutions and has advanced fellowship training in MD (Radiation Oncology)
Every case is personally reviewed. Treatment plans are tailored, transparent, and discussed in detail before you make any decisions or travel arrangements.
Post-operative or primary radiation for all stages; prone-position techniques reduce cardiac dose.
External beam IMRT combined with HDR brachytherapy for definitive and adjuvant treatment.
Definitive and adjuvant IMRT/VMAT for oral, laryngeal, thyroid, and salivary gland tumours.
SBRT/SABR for early-stage; chemoradiation for locally advanced; prophylactic cranial irradiation for SCLC.
Stereotactic radiosurgery (SRS), WBRT, and fractionated SRT for primary and metastatic brain tumours.
Neoadjuvant chemoradiation (short or long course) for rectal cancer prior to surgery.
Involved-site radiotherapy (ISRT) for Hodgkin's and aggressive non-Hodgkin's lymphoma.
SBRT for liver metastases, hepatocellular carcinoma, and pancreatic cancer.
External beam IMRT, SBRT (5-fraction), and HDR brachytherapy boost for all risk groups.
Intensity-modulated and volumetric-modulated arc therapy for precise dose delivery to tumour while sparing normal tissue.
Stereotactic body radiotherapy delivering ablative doses in 1–5 fractions for early-stage and oligometastatic disease.
Single or multi-session stereotactic radiosurgery for intracranial targets with sub-millimetre precision.
Internal radiation therapy delivering high doses directly to the tumour with minimal exposure to surrounding tissue.
Palliative and prophylactic whole brain radiotherapy with hippocampal avoidance to preserve memory.
Send your medical reports and get a personalised treatment plan. The team reviews cases from 50+ countries and responds within 24 hours.
Our team responds within 24 hours
Share your reports and receive a personalised treatment recommendation within 48 hours — at no cost.